DK0975668T3 - Modificerede TNFa-molekyler, DNA, der koder for sådanne modificerede TNFa-molekyler og vacciner omfattende sådanne modificerede TNFa-molekyler og DNA - Google Patents
Modificerede TNFa-molekyler, DNA, der koder for sådanne modificerede TNFa-molekyler og vacciner omfattende sådanne modificerede TNFa-molekyler og DNAInfo
- Publication number
- DK0975668T3 DK0975668T3 DK98916866T DK98916866T DK0975668T3 DK 0975668 T3 DK0975668 T3 DK 0975668T3 DK 98916866 T DK98916866 T DK 98916866T DK 98916866 T DK98916866 T DK 98916866T DK 0975668 T3 DK0975668 T3 DK 0975668T3
- Authority
- DK
- Denmark
- Prior art keywords
- tnfα molecules
- modified tnfα
- dna
- modified
- molecules
- Prior art date
Links
- 108060008682 Tumor Necrosis Factor Proteins 0.000 title 3
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 title 3
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/525—Tumour necrosis factor [TNF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/14—Lymphokine; related peptides
- Y10S930/144—Tumor necrosis factor
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Diabetes (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Hematology (AREA)
- Neurosurgery (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK41897 | 1997-04-15 | ||
US4418797P | 1997-04-24 | 1997-04-24 | |
EP98916866A EP0975668B1 (en) | 1997-04-15 | 1998-04-15 | MODIFIED TNFalpha MOLECULES, DNA ENCODING SUCH MODIFIED TNFalpha MOLECULES AND VACCINES COMPRISING SUCH MODIFIED TNFalpha MOLECULES AND DNA |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0975668T3 true DK0975668T3 (da) | 2006-09-25 |
Family
ID=8093298
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK98916866T DK0975668T3 (da) | 1997-04-15 | 1998-04-15 | Modificerede TNFa-molekyler, DNA, der koder for sådanne modificerede TNFa-molekyler og vacciner omfattende sådanne modificerede TNFa-molekyler og DNA |
Country Status (30)
Country | Link |
---|---|
US (1) | US7118750B1 (ja) |
EP (1) | EP0975668B1 (ja) |
JP (1) | JP2001521386A (ja) |
KR (1) | KR100522289B1 (ja) |
CN (1) | CN1178955C (ja) |
AR (1) | AR012427A1 (ja) |
AT (1) | ATE326481T1 (ja) |
AU (1) | AU743400B2 (ja) |
BR (1) | BR9811462A (ja) |
CA (1) | CA2289476A1 (ja) |
CZ (1) | CZ9903657A3 (ja) |
DE (1) | DE69834556T2 (ja) |
DK (1) | DK0975668T3 (ja) |
EE (1) | EE9900461A (ja) |
ES (1) | ES2264569T3 (ja) |
HK (1) | HK1022918A1 (ja) |
HR (1) | HRP980203B1 (ja) |
HU (1) | HUP0001930A3 (ja) |
IL (1) | IL132281A0 (ja) |
NO (1) | NO995002L (ja) |
NZ (1) | NZ337955A (ja) |
PL (1) | PL194221B1 (ja) |
RU (1) | RU2241715C2 (ja) |
SI (1) | SI0975668T1 (ja) |
SK (1) | SK285639B6 (ja) |
TR (1) | TR199902562T2 (ja) |
TW (1) | TW510921B (ja) |
UA (1) | UA72440C2 (ja) |
WO (1) | WO1998046642A1 (ja) |
ZA (1) | ZA983148B (ja) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080050367A1 (en) | 1998-04-07 | 2008-02-28 | Guriq Basi | Humanized antibodies that recognize beta amyloid peptide |
TWI239847B (en) | 1997-12-02 | 2005-09-21 | Elan Pharm Inc | N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease |
US6913749B2 (en) | 1998-11-02 | 2005-07-05 | Resistentia Pharmaceuticals Ab | Immunogenic polypeptides for inducing anti-self IgE responses |
EP1159003B1 (en) * | 1999-03-02 | 2010-11-17 | Centocor, Inc. | Anti-tnf alpha antibodies in therapy of steroid resistant asthma |
US20040220103A1 (en) | 1999-04-19 | 2004-11-04 | Immunex Corporation | Soluble tumor necrosis factor receptor treatment of medical disorders |
WO2000067777A1 (en) * | 1999-05-07 | 2000-11-16 | Biofan Pty Ltd | A method of prophylaxis and treatment and agents useful therefor |
US7056512B1 (en) | 1999-07-20 | 2006-06-06 | Pharmexa A/S | Method for down-regulating GDF-8 activity |
EP1296709A1 (en) * | 2000-06-21 | 2003-04-02 | Ferring BV | Solubilised protein vaccines |
AU2003208314A1 (en) * | 2002-03-11 | 2003-09-22 | Pharmexa A/S | Novel application of vaccination against tnf-alpha |
FR2844514B1 (fr) * | 2002-09-16 | 2007-10-19 | Neovacs | Produit immunogene stable comprenant des heterocomplexes antigeniques, compositions les contenant et procede de preparation |
US7563810B2 (en) * | 2002-11-06 | 2009-07-21 | Celgene Corporation | Methods of using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myeloproliferative diseases |
US8034831B2 (en) | 2002-11-06 | 2011-10-11 | Celgene Corporation | Methods for the treatment and management of myeloproliferative diseases using 4-(amino)-2-(2,6-Dioxo(3-piperidyl)-isoindoline-1,3-dione in combination with other therapies |
PL378571A1 (pl) * | 2003-02-01 | 2006-05-02 | Neuralab Limited | Czynna immunizacja dla wytworzenia przeciwciał przeciw rozpuszczalnemu A-ß |
MXPA06009805A (es) * | 2004-02-27 | 2007-04-02 | Vaxconsulting | Peptidos de interleucina 1 beta y factor de necrosis tumoral alfa y metodo de tratamiento utilizando los mismos. |
US8916165B2 (en) | 2004-12-15 | 2014-12-23 | Janssen Alzheimer Immunotherapy | Humanized Aβ antibodies for use in improving cognition |
CA2903138A1 (en) | 2005-05-16 | 2006-11-23 | Abbvie Biotechnology Ltd. | Use of tnfa inhibitor for treatment of erosive polyarthritis |
US9605064B2 (en) | 2006-04-10 | 2017-03-28 | Abbvie Biotechnology Ltd | Methods and compositions for treatment of skin disorders |
WO2009040361A1 (en) * | 2007-09-25 | 2009-04-02 | Intervet International B.V. | Vaccine for the treatment of osteoarthritis |
JO3076B1 (ar) | 2007-10-17 | 2017-03-15 | Janssen Alzheimer Immunotherap | نظم العلاج المناعي المعتمد على حالة apoe |
US9067981B1 (en) | 2008-10-30 | 2015-06-30 | Janssen Sciences Ireland Uc | Hybrid amyloid-beta antibodies |
US9527915B2 (en) | 2009-11-05 | 2016-12-27 | The Uab Research Foundation | Treating basal-like genotype cancers |
US8703712B2 (en) | 2010-03-18 | 2014-04-22 | The Uab Research Foundation | Targeting cancer stem cells with DR5 agonists |
US8907053B2 (en) * | 2010-06-25 | 2014-12-09 | Aurigene Discovery Technologies Limited | Immunosuppression modulating compounds |
EP2462950A1 (en) | 2010-12-08 | 2012-06-13 | Neovacs | Strongly inactivated and still highly immunogenic vaccine, and process of manufacturing thereof |
CN103347536A (zh) | 2010-12-08 | 2013-10-09 | 尼奥瓦克斯公司 | 强灭活且仍高免疫原性的疫苗及其制备方法 |
CN102539778A (zh) * | 2010-12-24 | 2012-07-04 | 北京义翘神州生物技术有限公司 | 一种检测人肿瘤坏死因子-α的酶联免疫试剂盒 |
JP2011201902A (ja) * | 2011-05-19 | 2011-10-13 | Wyeth Llc | 可溶性A−βに対する抗体を生成させるための能動免疫 |
CN103376327A (zh) * | 2012-04-28 | 2013-10-30 | 通用电气公司 | 检测抗体或融合蛋白的浓度的方法 |
AU2016256876B2 (en) | 2015-05-05 | 2021-02-04 | Rubicon Biotechnology Llc | Cancer immunotherapeutic |
CN106279403B (zh) * | 2016-08-16 | 2019-06-11 | 长春市海兰深生物医学技术有限公司 | 一种检测天然肺癌相关抗体的组合物、试剂盒和方法 |
CN106478802B (zh) * | 2016-10-11 | 2019-08-09 | 浙江省人民医院 | TNF-α蛋白B细胞表位,含此表位的多抗原肽及应用 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3750056T2 (de) | 1986-06-20 | 1995-04-06 | Dainippon Pharmaceutical Co | Polypeptid-Mutanten des menschlichen TNF und für diese Mutanten codierende DNS. |
DE3843534A1 (de) * | 1988-12-23 | 1990-07-12 | Basf Ag | Neue tnf-polypeptide |
US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
AU634379B2 (en) | 1991-04-29 | 1993-02-18 | Csl Limited | Recombinant immunocastration vaccine |
SE9102808L (sv) * | 1991-09-26 | 1993-03-27 | Lars T Hellman Inst F Immunolo | Vaccin, foer humant bruk, vars avsedda effekt aer att lindra symptomen eller foerhindra uppkomsten av ige-medierade allergiska reaktioner |
CA2119089A1 (en) * | 1993-03-29 | 1994-09-30 | David Banner | Tumor necrosis factor muteins |
DK96493D0 (da) | 1993-08-26 | 1993-08-26 | Mouritsen Og Elsner Aps | Fremgangsmaade til at inducere antistofresponser mod selvproteiner og autovaccine fremstillet ved fremgangsmaaden |
-
1998
- 1998-04-15 HU HU0001930A patent/HUP0001930A3/hu unknown
- 1998-04-15 US US09/060,294 patent/US7118750B1/en not_active Expired - Fee Related
- 1998-04-15 HR HR980203A patent/HRP980203B1/xx not_active IP Right Cessation
- 1998-04-15 UA UA99116210A patent/UA72440C2/uk unknown
- 1998-04-15 EP EP98916866A patent/EP0975668B1/en not_active Expired - Lifetime
- 1998-04-15 CZ CZ19993657A patent/CZ9903657A3/cs unknown
- 1998-04-15 AT AT98916866T patent/ATE326481T1/de not_active IP Right Cessation
- 1998-04-15 AU AU70303/98A patent/AU743400B2/en not_active Ceased
- 1998-04-15 AR ARP980101722A patent/AR012427A1/es unknown
- 1998-04-15 IL IL13228198A patent/IL132281A0/xx unknown
- 1998-04-15 CA CA002289476A patent/CA2289476A1/en not_active Abandoned
- 1998-04-15 KR KR10-1999-7009504A patent/KR100522289B1/ko not_active IP Right Cessation
- 1998-04-15 PL PL98336295A patent/PL194221B1/pl not_active IP Right Cessation
- 1998-04-15 SK SK1409-99A patent/SK285639B6/sk unknown
- 1998-04-15 SI SI9830845T patent/SI0975668T1/sl unknown
- 1998-04-15 WO PCT/DK1998/000157 patent/WO1998046642A1/en not_active Application Discontinuation
- 1998-04-15 JP JP54338798A patent/JP2001521386A/ja active Pending
- 1998-04-15 DK DK98916866T patent/DK0975668T3/da active
- 1998-04-15 CN CNB988042142A patent/CN1178955C/zh not_active Expired - Fee Related
- 1998-04-15 RU RU99122686/13A patent/RU2241715C2/ru not_active IP Right Cessation
- 1998-04-15 ZA ZA9803148A patent/ZA983148B/xx unknown
- 1998-04-15 DE DE69834556T patent/DE69834556T2/de not_active Expired - Fee Related
- 1998-04-15 NZ NZ337955A patent/NZ337955A/xx unknown
- 1998-04-15 TR TR1999/02562T patent/TR199902562T2/xx unknown
- 1998-04-15 BR BR9811462-0A patent/BR9811462A/pt not_active Application Discontinuation
- 1998-04-15 EE EEP199900461A patent/EE9900461A/xx unknown
- 1998-04-15 ES ES98916866T patent/ES2264569T3/es not_active Expired - Lifetime
- 1998-07-20 TW TW087111808A patent/TW510921B/zh not_active IP Right Cessation
-
1999
- 1999-10-14 NO NO995002A patent/NO995002L/no not_active Application Discontinuation
-
2000
- 2000-03-23 HK HK00101819A patent/HK1022918A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0975668T3 (da) | Modificerede TNFa-molekyler, DNA, der koder for sådanne modificerede TNFa-molekyler og vacciner omfattende sådanne modificerede TNFa-molekyler og DNA | |
IS5525A (is) | Innúðabúnaður og aðferð | |
NO20016243D0 (no) | Anti-alfav-beta3-rekombinante humane antistoffer, nukleinsyrer som koder for de samme og fremgangsmåter foranvendelse | |
DK1490386T3 (da) | Nyt polypeptid og nukleinsyrer kodende for dette | |
DE69533634D1 (de) | Geranylgeranyldiphosphate-Synthase und diese kodierende DNA | |
DK1071767T3 (da) | Gen, der koder for heliomicin, og anvendelse heraf | |
NO20001552L (no) | Katalysator og fremgangsmÕter hvor slike benyttes | |
DE69718600D1 (de) | Polyether-Nukleinsäuren | |
FR2776928B1 (fr) | Vaccins adn adjuves | |
ID19836A (id) | Metoda dan apparatus pengkodean dan pemecahan-kode data digit | |
EP1001964A4 (en) | TANGO-78, TANGO-79 AND TANGO-81 NUCLEIC ACID MOLECULES | |
NO20013102L (no) | Gener, proteiner og deres anvendelse | |
ZA9710163B (en) | Novel carboxylesterase nucleic acid molecules, proteins and uses thereof. | |
DK0791591T3 (da) | Benzothiophener, formuleringer indeholdende samme og fremgangsmåder til deres fremstilling | |
NL1010171A1 (nl) | Reed-Solomon decoderingsinrichting en decoderingswerkwijze. | |
GB9421093D0 (en) | Hippocampus-associated proteins, DNA sequences coding therefore and uses thereof | |
CY1105287T1 (el) | Ορχεως - ειδικη ανθρωπινη svph1-8 πρωτεϊναση | |
NO20003268D0 (no) | Hyperhydrert kitikolin, fremgangsmÕte og anvendelse | |
NO20020919D0 (no) | Irenprotein, dets fremstilling og anvendelse | |
NO308213B1 (no) | Substituerte indanylidinacetylguanidiner, deres anvendelse og medikamenter inneholdende forbindelsene | |
EP1044216A4 (en) | DNA MOLECULES ENCODING HUMAN NUCLEAR RECEPTOR PROTEINS, nNR7 AND nNR7-1 | |
DE69532881D1 (de) | Ecdn - protein und dafuer kodeierende dna | |
EP0970192A4 (en) | NUCLEIC ACID ENCODING AN ALGU $ i PROTEIN (M. TUBERCULOSIS) | |
IS4987A (is) | PTX næm G prótein, framleiðsla þeirra og notkun | |
EP1331943A4 (en) | NUCLEIC ACID MOLECULES AND POLYPEPTIDES FOR IMMUNOMODULATION |